Practice Areas -

Equity Capital Markets Law Firms and Lawyers

  • Search Result as
  • By Days
  • Between Dates

Practice Areas - Equity Capital Markets Law Firms and Lawyers

Deal Date: 14-07-2020 Practice Area: Equity Capital Markets
Deal Title: Revolution Medicines Common Stock Follow-On Offering Industry: Pharmaceuticals & Biotechnology
Davis Polk advised the underwriters in connection with a public offering of 6,900,000 shares of common stock of Revolution Medicines, Inc. at USD26.00 per share (which included the exercise in full by the underwriters of their option to purchase up to 900,000 additional shares), for total gross proceeds of USD179.4 million. The common stock was listed on the Nasdaq Global Select Market under the symbol RVMD. Based in Redwood City, California, Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
Financial Center: Silicon Valley Value: 100.01-500.00
Advised Party: Underwriter Law Firm
Issuer Jurisdiction - United States Listing Jurisdiction - United States
Classification: Secondary Offerings and Placings NASDAQ:
Lawyer Alan F Denenberg